| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 3 buys and 31 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.22M | $9.79M | - | |
| CFO | 235.0K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | Vera Juan | Director | Sell | 17,860 | $41.23 | $736,294.95 | -0.1% | |
| Feb 17, 2021 | Van Beek Jeroen B85 | Chief Commercial Officer | Sell | 5,400 | $41.22 | $222,606.96 | -0.2% | |
| Feb 17, 2021 | Leen Ann M.83 | Chief Scientific Officer | Sell | 5,336 | $41.27 | $220,200.62 | - | |
| Feb 17, 2021 | Hagen Brett R84 | Chief Accounting Officer | Sell | 5,370 | $41.26 | $221,579.49 | -1.3% | |
| Feb 17, 2021 | Brenner Malcolm | Director | Sell | 11,385 | $41.22 | $469,256.95 | -0.2% | |
| Feb 2, 2021 | Van Beek Jeroen B85 | Chief Commercial Officer | Sell | 48,910 | $41.19 | $2,014,602.90 | -8.7% | |
| Feb 2, 2021 | Melian Agustin83 | Chief Medical Officer | Sell | 54,849 | $41.19 | $2,259,230.31 | -9.5% | |
| Aug 3, 2020 | Van Beek Jeroen B85 | Chief Commercial Officer | Buy | 3,000 | $17.00 | $51,000.00 | +0.6% | |
| Aug 3, 2020 | Atillasoy Ercem78 | See Remarks | Buy | 3,500 | $17.00 | $59,500.00 | +4.7% | |
| Aug 3, 2020 | Brainard Diana85 | Director | Buy | 6,300 | $17.00 | $107,100.00 | New |